Design, Synthesis, and Biological Evaluation of Peptidomimetic Tetrahydropyrrole Spirodihydroindolones as SARS-CoV-2 3CL Protease Inhibitors
Year: 2025
Type: article
Abstract: The 3CL protease (3CL pro ) of SARS-CoV-2 is a key enzyme that plays an essential role in mediating viral replication and transcription. In this study, we synthesized and evaluated a series of peptidomimetic compounds containing a tetrahydropyrrole spirodihydroindolone moiety. Among the target compounds, 13c and 17d exhibited obvious 3CL pro inhibitory activities with IC 50 = 3.71 and 6.21 nM, respectively. In metabolic stability testing of liver microsomes, compound 13c showed improved stability in human liver microsomes. In addition, 13c displayed significant anti-SARS-CoV-2 activity and high safety in Vero E6 cells (EC 50 = 19.26 nM, SI > 400). Further investigations indicated that 13c showed potent activity against HCoV-OC43 and favorable safety in Huh7 cells (EC 50 = 61 nM, SI > 100). These findings suggest that compound 13c is a promising lead compound in the development of novel 3CL pro inhibitors.
Source: ACS Medicinal Chemistry Letters
Institutions: Anhui University of Traditional Chinese Medicine, Wuhan Union Hospital, Huazhong University of Science and Technology, Chinese Academy of Sciences, Shanghai Institute of Materia Medica, University of Chinese Academy of Sciences, State Key Laboratory of Drug Research, Wuhan Institute of Virology, State Key Laboratory of Virology
Language: English
Subfield: Infectious Diseases
Field: Medicine
Domain: Health Sciences
Open Access status: green
Awards: G4155882180, G901371455
OpenAlex ID: W4409412992
